Roche looks to bring evidence-based medicine tech to India

MUMBAI: Swiss drug maker Roche is looking for startups in India that will help the company bring evidence-based medicine in India through its proprietary technology, according to the company’s newly appointed India head.

Lara Bezerra, Roche Managing Director (India), who moved from the troubled Venezuela market to India, told ET that as part of its long-term strategy the company can bring applications of Flatiron, a tech company that it acquired this year to India.

Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software, as well as the curation and development of real-world evidence for cancer research.

Roche during the acquisition of the company in February said that with its large network of community oncology practices and academic medical centres across the US, Flatiron Health has created a technology platform designed to learn from the experience of every patient.

“When we are having this vision for India we realised that whatever you do in India you can’t do in short term. So we have to think something long term. So we are looking how should we bring Flatiron tech to India,” said Benzerra. “May be there is startup in India that can work with Flatiron so we are looking at all these options.”

Millions of patient profile is matched through this tech and the doctor is provided with the best possible outcomes that these kinds of patients have. So along with medical judgement the doctor has an option to lean into this data base too, explained V Simpson Emmanuel, Director, Market Access, Roche India.

  • Related Posts

    • Pharma
    • March 27, 2024
    • 104 views
    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

    • Pharma
    • March 27, 2024
    • 69 views
    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down